Skip to main content

Advertisement

Table 1 Baseline characteristics of the studied cohort relative to the presence of events

From: Prognostic value of the Stanniocalcin-2/PAPP-A/IGFBP-4 axis in ST-segment elevation myocardial infarction

Variable All patients (n = 1085) Without events (n = 909) With events (n = 176) p value
Age (years) 62 (52–73) 59 (51–69) 76 (66–81) < 0.001
Female 241 (22.2) 187 (20.6) 54 (30.7) 0.003
Hypertension 598 (55.1) 473 (52.0) 125 (71.0) 0.001
Diabetes mellitus 276 (25.4) 208 (22.9) 68 (38.6) < 0.001
Dyslipidemia 645 (59.5) 550 (60.5) 95 (54.0) 0.106
Cerebrovascular disease 69 (6.4) 42 (4.6) 27 (15.3) < 0.001
Peripheral arterial disease 77 (7.1) 57 (6.3) 20 (11.4) 0.016
Heart failure 18 (1.7) 7 (0.8) 11 (6.3) < 0.001
Coronary artery disease 236 (21.8) 188 (20.7) 48 (27.3) 0.052
Myocardial infarction 103 (9.5) 76 (8.4) 27 (15.3) 0.004
Killip–Kimball I–II 1009 (93.0) 877 (96.5) 132 (75.0) < 0.001
Killip–Kimball III–IV 76 (7.0) 32 (3.5) 44 (25.0) < 0.001
BMI (kg/m2) 27.3 (24.8–29.9) 27.2 (24.8–29.8) 27.6 (24.3–30.0) 0.944
Hs-TnT, peak (ng/L) 2752 (1021–6057) 2643 (934–5590) 4375 (1357–91,485) < 0.001
NT-ProBNP, peak (ng/L) 1003 (395–2421) 827 (356–1707) 3461 (1569–7396) < 0.001
LVEF (%) 52 (45–58) 54 (47–59) 45 (38–53) < 0.001
Main epicardial coronary arteries > 70% stenosis
 1 564 (52.0) 493 (54.2) 71 (40.3) 0.001
 2 287 (26.5) 253 (27.8) 34 (19.3) 0.019
 3 212 (19.5) 155 (17.1) 57 (32.4) < 0.001
Left main ≥ 50% stenosis 40 (3.7) 25 (2.8) 15 (8.5) < 0.001
  1. Data represent the number (%) or median (interquartile range). Wilcoxon Rank-sum test was used for comparisons of continuous variables
  2. PCI percutaneous coronary intervention, BMI body mass index, hs-TnT high-sensitivity troponin T, LVEF left ventricular ejection fraction